Search

9010 results for: ‘h5版仿鱼泡网源码-招工招聘找活名片信息分类同城工地招工网站源码tp框架✅项目合作 二开均可 TG:saolei44✅.gQRrYtKpbWg’

  • Leicester Professor co-chairs expert panel behind new recommendations for type 2 diabetes

    Leicester researcher co-chairs expert panel behind new EASD-ADA consensus guidelines on managing hyperglycaemia in type 2 diabetes.

  • Esteemed academics from top UK universities to take part in Black in Academia panel event at Leicester

    An upcoming event at the University of Leicester will see some of Britain’s leading academic minds take part in a discussion on equality in Higher Education on Thursday 26 October.

  • Garden preview

    Discover all there is to see at the Botanic Garden at the University of Leicester.

  • Blood signature could improve early TB diagnosis

    A gene signature in the bloodstream could reveal whether someone is going to develop active tuberculosis (TB) disease months before symptoms begin, research has shown.

  • 9th Dec. 2013 Sol 478

    Posted by jbridges in Mars Science Laboratory Blog on December 9, 2013 Today is when the first set of papers about Yellowknife Bay are published.

  • 17th Dec. 2013 Sol 485

    Posted by jbridges in Mars Science Laboratory Blog on December 17, 2013 The landing site slection process for the 2018 ExoMars Rover has just started: http://exploration.esa.

  • Technology and Type 1 Diabetes

    Module code: MD7527 This exciting new module ‘Technology and Type 1 Diabetes’ led by Professor Pratik Choudhury brings together the most current thinking on technology and how it is used to support people living with Type 1 diabetes.

  • Technology and Type 1 Diabetes

    Module code: MD7527 This exciting new module ‘Technology and Type 1 Diabetes’ led by Professor Pratik Choudhury brings together the most current thinking on technology and how it is used to support people living with Type 1 diabetes.

  • Technology and Type 1 Diabetes

    Module code: MD7527 This exciting new module ‘Technology and Type 1 Diabetes’ led by Professor Pratik Choudhury brings together the most current thinking on technology and how it is used to support people living with Type 1 diabetes.

  • Study reviews new once-weekly Type 2 diabetes drugs

    Once-weekly glucagon-like peptide-1 receptor agonists (GLP-1RAs) differ in their efficacy and safety profiles, according to new research by researchers from the Leicester Diabetes Centre. Compared to other once-weekly GLP-1RAs which are licensed and available, dulaglutide 1.

Back to top
MENU